Physician profile
David P Choe
NPI 1558575522
$1,510.41
in general payments reported to CMS, 2019-2025
17 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $33.23 · 2021: $185 · 2022: $476 · 2023: $339 · 2024: $15.40 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $245.20 | 2022-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $229.96 | 2020-2025 | Xience Skypoint, Cardiomems, Pressurewire |
| E.R. Squibb & Sons, L.L.C. | $160.99 | 2022-2023 | |
| Esperion Therapeutics, INC. | $125.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.34 | 2025 | |
| Amgen INC. | $121.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.28 | 2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $86.03 | 2019 | |
| Chiesi USA, INC. | $78.18 | 2021-2023 | Kengreal, Cleviprex |
| Boston Scientific Corporation | $39.70 | 2020-2022 | |
| Philips North America LLC | $38.94 | 2021 | |
| Medtronic, INC. | $38.50 | 2025 | Linq II |
| Novartis Pharmaceuticals Corporation | $33.37 | 2022 | |
| Becton, Dickinson and Company | $26.18 | 2025 | Hemosphere |
| Ge Healthcare | $25.41 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $20.10 | 2022 | |
| Dentsply Sirona INC | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Choe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.